Join
Live feed
·
INSIDERFilingvia Quantisnow
Poseida Therapeutics Inc. logo

Director Schmid John P. closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PSTX· Poseida Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PSTX (Poseida Therapeutics Inc.) and more on Quantisnow.